Caring Cross Deal History & Licensing Activity
Caring Cross is a life sciences. Over the past three years, Caring Cross has been involved in 1 licensing and acquisition transaction, with a primary focus on Gene Therapy (2 deals). The company currently has 1 active clinical trial, primarily in Hematology.
Deals (12mo)
2
Active Trials
1
Top Modality
Gene Therapy
Focus Area
Hematology
Caring Cross Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Caring Cross in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| BCL11A-LCRshRNAmiR lentiviral technology | Boston Children's Hospital | Gene Therapy | Preclinical | license | Mar 2026 |
Caring Cross Pipeline Focus
Therapeutic areas and modalities where Caring Cross is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Caring Cross Clinical Pipeline
Caring Cross has 1 active clinical trial across 1 development phase.
1
Phase 1
See How Your Asset Matches Caring Cross's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Hematology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Hematology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for hematology
Gene Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for gene therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Caring Cross Licensing & Deal Activity
Caring Cross is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Caring Cross ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Caring Cross include Hematology (2 deals and trials), and Infectious (1 deal and trial). In terms of modality, Caring Cross has shown particular interest in gene therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Caring Cross and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Caring Cross's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.